Home MDWD
loading
Oct-07-22 06:00AM MediWound Announces Closing of the Concurrent Registered Direct and Private Placement OfferingsGlobeNewswire Inc.
Sep-23-22 03:42AM Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From YesterdayBenzinga
Sep-22-22 03:10AM Dow Turns Higher; Crude Oil Rises 0.7%Benzinga
12:26PM Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day SessionBenzinga
Sep-22-22 12:26PM Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike HigherBenzinga
08:02AM MediWound Announces Concurrent Registered Direct and Private Placement Offerings Priced At-the-Market of Approximately $30 MillionGlobeNewswire Inc.
Aug-09-22 08:45AM MediWound (MDWD) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research
07:30AM MediWound Reports Second Quarter 2022 Financial Results and Provides Company UpdatesGlobeNewswire Inc.
Aug-08-22 05:35AM FibroGen (FGEN) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research
04:05AM MediWound Enhances Its Board and Executive Leadership TeamGlobeNewswire Inc.
May-17-22 08:15AM MediWound (MDWD) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research
07:01AM MediWound Announces CEO TransitionGlobeNewswire Inc.
May-16-22 05:25AM Ayala Pharmaceuticals, Inc. (AYLA) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research
May-12-22 05:35AM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research
08:42AM The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And MoreBenzinga
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Cap:    |  Volume (24h):